Browsing Tag

Nimbus

Anagenex and Nimbus Therapeutics (Nimbus) announced they have initiated a research collaboration. Anagenex, a pioneering drug discovery company…

Machine Learning

Nimbus Therapeutics Announces Closing of Takeda’s Acquisition of TYK2 Subsidiary

AIT News Desk Feb 9, 2023

Nimbus Therapeutics, LLC (“Nimbus Therapeutics” or “Nimbus”), a clinical-stage company that designs and develops breakthrough medicines through its…

Machine Learning

Daily AI Roundup: Biggest Machine Learning, Robotic And Automation Updates

AIT Staff Writer Dec 21, 2022

This is our AI Daily Roundup today. We are covering the top updates from around the world. The updates will feature state-of-the-art capabilities in …

Technology

Start.io Partners with Nimbus to Maximize Mobile App Monetization with In-App Bidding Direct…

AIT News Desk Dec 20, 2022

Start.io, the fourth most popular SDK in the world and the leading independent monetization software, introduces a partnership with Nimbus, a…

Technology

Takeda to Acquire Nimbus Therapeutics’ Highly Selective, Allosteric TYK2 Inhibitor to Address…

AIT News Desk Dec 14, 2022

- Nimbus to receive $4 billion in upfront cash, and up to $2 billion in commercial milestone payments - - NDI-034858 has potential best-in-class…

Cloud

Tricentis Releases New Research on the Rise of Enterprise Application Testing

AIT News Desk Nov 18, 2020

Tricentis, the world’s #1 testing platform for modern cloud and enterprise applications, has released new research in partnership with Nimbus Ninety…